Fig. 2From: In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancerBackground- and decay-corrected cell counts across 48Â h representing A surface binding, B internalised fraction, C total binding including surface and internalised and D rate of internalisationBack to article page